Dmd #3244r Hepatic Uptake of the Novel Antifungal Agent Caspofungin

نویسندگان

  • Punam Sandhu
  • Wooin Lee
  • Xin Xu
  • Brenda F. Leake
  • Masayo Yamazaki
  • Julie A. Stone
  • Jiunn H. Lin
  • Paul G. Pearson
  • Richard B. Kim
چکیده

Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA (W.L., B.F.L., R.B.K.) and Department of Drug Metabolism, Merck Research Laboratories, West Point, PA, USA (P.S., X.X., M.Y., J.A.S., J. H. L., P.G.P). *Current address: Department of Drug Safety and Metabolism, Wyeth Pharmaceuticals, 1 Burtt Road, Andover, MA 01810 **Current address: Department of Pharmacokinetics and Drug Metabolism, Amgen, Thousand Oaks, CA 91320 DMD Fast Forward. Published on February 16, 2005 as doi:10.1124/dmd.104.003244

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hepatic uptake of the novel antifungal agent caspofungin.

Caspofungin (CANCIDAS, a registered trademark of Merck & Co., Inc.) is a novel echinocandin antifungal agent used in the treatment of esophageal and invasive candidiases, invasive aspergillosis, and neutropenia. Available data suggest that the liver is a key organ responsible for caspofungin elimination in rodents and humans. Caspofungin is primarily eliminated by metabolic transformation; howe...

متن کامل

Caspofungin: the first agent available in the echinocandin class of antifungals.

Caspofungin acetate (Cancidas, MK-0991, L-743,872) is a parenteral antifungal agent indicated in the treatment of invasive aspergillosis in patients who are intolerant of or whose infection is refractory to other antifungal therapies. It is the first member of a novel class of antifungals, the echinocandins, to be made available in the USA. As a class, the echinocandins possess a mechanism of a...

متن کامل

Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys.

The metabolism, excretion, and pharmacokinetics of caspofungin (Cancidas; Merck & Co., Inc.) were investigated after administration of a single intravenous dose to mice, rats, rabbits, and monkeys. Caspofungin had a low plasma clearance (0.29 to 1.05 ml/min/kg) and a long terminal elimination half-life (11.7 h to 59.7 h) in all preclinical species. The elimination kinetics of caspofungin were m...

متن کامل

Application of caspofungin in China compared with amphotericin B and fluconazole

Fungal infection has increased in the past 2 decades in China. There are three classes of antifungal drugs, polyenes, azoles, and echinocandins, that are applied frequently in China. Caspofungin, which disrupts the fungal cell wall glucan formation through inhibiting the enzyme 1,3-β-glucan synthase, is one of the echinocandins. According to the results of clinical practices applied in China, c...

متن کامل

In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.

The purpose of the present study was to elucidate the transport mechanisms responsible for elimination of micafungin, a new semisynthetic echinocandin antifungal agent, which is predominantly cleared by biliary excretion in humans and rats. In vitro studies using sandwich-cultured rat and human hepatocytes were conducted. Micafungin uptake occurred primarily (∼75%) by transporter-mediated mecha...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2005